Today: 21 May 2026
Gold price near $5,000 after wild week; jobs and CPI set the next test
8 February 2026
2 mins read

Gold price near $5,000 after wild week; jobs and CPI set the next test

New York, February 8, 2026, 12:02 EST — The market’s final bell has sounded.

  • Gold jumped 3.9% on Friday, trading close to $4,955 an ounce, while U.S. futures finished just under $4,980.
  • CME raised margin requirements for both gold and silver once more, with volatility still running high.
  • With the dollar and rates once again drawing attention, traders now look ahead to Feb. 11 payrolls and the Feb. 13 CPI release.

Gold is set to kick off the week just shy of $5,000 an ounce, following a strong Friday bounce. A weaker dollar and new geopolitical developments pulled buyers back into bullion.

Markets are closed for now, so attention turns to what’s ahead: the bounce faces its first challenge from U.S. data once trading picks up again.

The past two weeks haven’t just been about macro moves—leverage has taken center stage. Sharp price swings led exchanges to crank up risk controls, while some investors slashed positions. The result: choppier price action than normal.

Spot gold jumped 3.9% to $4,954.92 an ounce as of 2:18 p.m. ET on Friday, on track for a roughly 2% gain for the week. U.S. gold futures for April ended up 1.8% at $4,979.80. The dollar index slipped 0.2%. According to Jim Wyckoff, senior analyst at Kitco Metals, the action points to “perceived bargain hunting,” though he doubts gold will find fresh highs unless there’s a “major geopolitical trigger.” Meanwhile, Iran’s top diplomat described talks with the United States in Oman as a “good start,” a comment that kept safe-haven flows alive. Reuters

Silver, platinum, and palladium staged a rebound Friday, underscoring how precious metals have recently been behaving more like a unified risk trade than traditional safe-haven assets.

CME Group bumped up initial and maintenance margins for COMEX 100-ounce gold futures, hiking the requirement to 9% from 8% for certain accounts. It also increased margins for COMEX 5,000-ounce silver futures, moving those to 18% from 15%. The changes kick in after Friday’s close. Margins—cash deposits needed to keep futures trades open—often go up when exchanges see volatility pick up, as a buffer against potential defaults.

Physical gold demand moved unevenly during the latest volatility. Indian dealers this week asked for premiums as high as $70 an ounce over official domestic prices, a sharp drop from last week’s $153, as unpredictable swings kept shoppers on edge. “Buyers were confused by the price swings,” said one Mumbai-based jeweller. Chinese interest on the dips, though, held up “very good” before the Lunar New Year, according to Peter Fung, head of dealing at Wing Fung Precious Metals. Reuters

Strategists are calling gold’s resilience a sign of relative strength. “Gold is kind of holding its own and silver is caving in under the risk-off,” said Ilya Spivak, head of global macro at Tastylive, flagging wider pressure across risk assets. Dawn

This week’s major signals: U.S. data delayed by the short government shutdown, with January payrolls landing Wednesday and CPI following Friday. On top of that, a handful of Federal Reserve officials are set to take the stage, adding fresh angles for traders beyond the metal trade.

January’s CPI numbers are set to drop Feb. 13, 8:30 a.m. ET, the Bureau of Labor Statistics shows on its release calendar.

Still, the recovery isn’t on solid ground. A strong inflation print or robust jobs data could push up the dollar and Treasury yields—moves that usually weigh on non-yielding gold. Sharper margin calls can also trigger fast selling, sometimes turning routine dips into sharper declines.

Asia reopens Monday, and all eyes are on bullion: does it hang onto that $5,000 mark, or get dragged back into last week’s turbulence? Following that, it’s Wednesday’s payrolls and Friday’s CPI that will really count.

Stock Market Today

  • Thales (ENXTPA:HO) Shares Decline but DCF Model Indicates Undervaluation
    May 21, 2026, 1:56 AM EDT. Shares of Thales (ENXTPA:HO) have fallen 12.8% over the past month and are down 9.7% year on year, despite strong long-term returns of 79.2% and 203.0% over three and five years respectively. Recent sector-specific developments in aerospace and defense, alongside broader market sentiment, contribute to price volatility. A discounted cash flow (DCF) analysis estimates Thales's intrinsic value at around €306.76 per share, suggesting the current price of €229.50 trades at a 25.2% discount and that the stock is undervalued. The P/E ratio remains a key metric but further valuation aspects need evaluation, as Thales scores 4 out of 6 on Simply Wall St's valuation checks. Investors should consider these factors when assessing the stock's potential.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Tencent stock price: WeChat AI “red packet” fight shadows Monday open after HK$547.50 close
Previous Story

Tencent stock price: WeChat AI “red packet” fight shadows Monday open after HK$547.50 close

Utilities stocks week ahead: XLU price ends higher, but CPI and jobs data loom
Next Story

Utilities stocks week ahead: XLU price ends higher, but CPI and jobs data loom

Go toTop